Page results
-
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.
-
We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.
-
A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the well being of doctors.
-
Today, 11 February, marks the tenth anniversary of the International Day of Women and Girls in Science, which seeks to bring gender equality in science and promote role models to inspire girls and women into scientific professions.
-
UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.
-
Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study at UCLH and UCL has found.
File results
-
FOI/2021/0559 - Department of Respiratory Physiology recall letter
-
FOI/2021/0572 - Dermatological and rheumatological conditions
-
FOI/2021/0577 - Patient brought to A&E paralysed
-
FOI/2021/0591 - Laboratory/ Pathology information system
-
FOI/2021/0593 - Contact centre/ Call centre contract
-
FOI/2021/0601 - Treatment Guidelines with Systemic lupus erythematosus (SLE) / Lupus nephritis (LN)
-
FOI/2021/0616 - Overseas visitors and migrants
-
FOI/2021/0618 - Number of patient admissions to A&E
-
FOI/2021/0626 - Cardiac output monitors and manufacturer associated disposable products
-
FOI/2021/0100 - DNACPR orders issued - March 2019 to January 2021